Biohaven Ltd. (NYSE: BHVN) (Biohaven), today announced that it will host a conference call to discuss topline data from Study BHV4157-206-RWE (NCT06529146), a study designed in discussion with the US ...

The data shows a significant reduction in mutant huntingtin protein in the cerebrospinal fluid of treated patients.

Considering taking supplements to treat spinocerebellar ataxia sca? Below is a list of common natural remedies used to treat or reduce the symptoms of spinocerebellar ataxia sca. Follow the links ...

Are you searching for medications to treat 'Spinocerebellar Ataxia'? Welcome to this page which serves as an archive for medications that are relevant to the treatment of Spinocerebellar Ataxia.

In 2004, Beverly Davidson and colleagues at the University of Iowa used this technique to treat mice with spinocerebellar ataxia, a neurological disorder akin to Huntington's. It was a landmark ...

Finally, to link these findings to neurodegenerative disorders, the researchers conducted experiments in cell cultures and mouse models of spinocerebellar ataxia type 1 (SCA1), a polyglutamine ...

Fintel reports that on September 16, 2024, Jefferies initiated coverage of Biohaven (NYSE:BHVN) with a Buy recommendation.

Researchers are studying how leukocyte telomere length may be associated with the progression of Friedreich's ataxia.

We are recruiting the following groups of participants to measure speech, breath control, laryngeal movements, and swallowing: Adults with spinocerebellar ataxia (any subtype) or Friedreich's Ataxia ...

As of 09:30AM EDT. Market open. Biohaven Ltd. (NYSE: BHVN) (Biohaven), today announced that it will host a conference call to discuss topline data from Study BHV4157-206-RWE (NCT06529146), a study ...